Laboratory Corporation of America Holdings and LipoScience, Inc., a provider of specialized cardiovascular diagnostic laboratory tests based on nuclear magnetic resonance (NMR) technology, have entered into a definitive merger agreement under which LabCorp will acquire LipoScience. The transaction is expected to close before the end of 2014.
“We are very pleased that LipoScience, a premier laboratory focused on personalized diagnostics for cardiovascular and metabolic disorders, is joining the LabCorp family,” says David P. King, Chairman and Chief Executive Officer of LabCorp. “LipoScience's NMR LipoProfile test will enhance our innovative clinical decision support programs as we provide ever-broader, differentiated knowledge services to physicians and patients.” Review LabCorp’s test menu.
Read more
